• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[从临床药理学角度看特殊治疗过程]

[Special therapeutic processes from the viewpoint of clinical pharmacology].

作者信息

Frölich J C

机构信息

Institut für Klinische Pharmakologie, Hannover.

出版信息

Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):681-5.

PMID:9527468
Abstract

Special therapies comprise homeopathic drugs, anthroposophic medicine and phytotherapy a heterogenous mixture, which consists partly on authorities (Hahnemann, Steiner) and partly describes the origin of the drug (herbal drugs). The field, therefore, is open to new additions (Chinese traditional medicine, American Indian drug therapy etc.). These drugs do not meet the requirements for safety and efficacy required for modern drugs and this is not required, because according to German lawyers this would be inadequate. We demonstrate examples where the health of patients has been severely damaged by this kind of medical therapies and point out that these problems continue. Reasons are presented, why the public has the right to demand proof of efficacy and safety of all drugs.

摘要

特殊疗法包括顺势疗法药物、人智医学和植物疗法,这是一种异质混合物,部分基于权威人士(哈内曼、施泰纳),部分描述药物的来源(草药)。因此,该领域对新的补充疗法开放(中医、美洲印第安药物疗法等)。这些药物不符合现代药物所需的安全性和有效性要求,而且也不需要符合,因为根据德国律师的说法,这是不充分的。我们展示了一些患者健康因这类医学疗法而受到严重损害的例子,并指出这些问题仍在继续。文中阐述了公众有权要求所有药物提供疗效和安全性证据的原因。

相似文献

1
[Special therapeutic processes from the viewpoint of clinical pharmacology].[从临床药理学角度看特殊治疗过程]
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):681-5.
2
[Special therapeutic guidelines from the viewpoint of BfArM (Federal Institute for Drug and Medical Products)].
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):669-74.
3
[Special therapeutic processes from the viewpoint of the lawyer].[从律师视角看特殊治疗过程]
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):685-90.
4
[Approval of drugs by national and European agencies--from the viewpoint of drug approval committee A].
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):600-3.
5
[Approval of drugs by national and European agencies--sequelae for the pharmaceutical industry].[国家和欧洲机构对药品的批准——制药行业的后遗症]
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):596-600.
6
[Special therapeutic practices from the viewpoint of naturopathy].
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):674-81.
7
[Modification of the prescribing practice of the physician by legislation with special reference to non-approved drugs].[通过立法对医生处方行为的规范,特别涉及未经批准的药物]
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):610-6.
8
[Modification of the prescribing practice of the physician by decisions of drug committees, specialty groups and consensus conferences].[药物委员会、专业团体及共识会议的决策对医生处方行为的影响]
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):606-10.
9
[Modification of the prescribing practice of the physician by drug approval decisions of federal agencies].[联邦机构的药物批准决定对医生处方行为的影响]
Z Arztl Fortbild Qualitatssich. 1997 Nov;91(7):604-6.
10
Reporting adverse events associated with herbal products.报告与草药产品相关的不良事件。
Clin J Oncol Nurs. 2000 May-Jun;4(3):137-8.